| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |